Filing Details
- Accession Number:
- 0001209191-22-057721
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-17 19:10:32
- Reporting Period:
- 2022-11-15
- Accepted Time:
- 2022-11-17 19:10:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1620463 | Athira Pharma Inc. | ATHA | Biological Products, (No Disgnostic Substances) (2836) | 453368487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1822494 | Hans Moebius | C/O Athira Pharma, Inc. 18706 North Creek Parkway, Suite 104 Bothell WA 98011 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-11-15 | 5,000 | $3.29 | 65,836 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
